Report of Foreign Issuer (6-k)
2020年5月18日 - 7:03PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
Report
of Foreign Private Issuer
Pursuant to Rule 13A-16
or 15d-16 of
The
Securities Exchange Act of 1934
For
the month of May 2020
COMMISSION
FILE Number.
000-29338
CORREVIO
PHARMA CORP.
(Translation
of registrant’s name into English)
1441
Creekside Drive, 6th floor
Vancouver,
British Columbia, V6J 4S7, CANADA
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
DOCUMENTS INCLUDED AS PART OF THIS REPORT
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
CORREVIO
PHARMA CORP.
|
|
(Registrant)
|
|
|
|
Date: May 15, 2020
|
By:
|
/s/
Justin Renz
|
|
|
Name: Justin Renz
|
|
|
Title: President and Chief Financial
Officer
|
Correvio Pharma (NASDAQ:CORV)
過去 株価チャート
から 5 2024 まで 6 2024
Correvio Pharma (NASDAQ:CORV)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Correvio Pharma Corporation (ナスダック市場): 0 recent articles
その他のCorrevio Pharma Corp.ニュース記事